RASopathy (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "RASopathy" in English language version.

refsWebsite

Global rank English rank

14nih.gov

4^th place

9doi.org

2^nd place

2worldcat.org

5^th place

1tandfonline.com

507^th place

429^th place

doi.org

Boxel-Woolf, Tom Van; McCarthy, Kathleen M. "Speech and language skills in a case of Watson syndrome". Clinical Linguistics & Phonetics. 0 (0): 1–24. doi:10.1080/02699206.2025.2472051. ISSN 0269-9206. PMID 40077991.
Rauen KA (2022). "Defining RASopathy". Disease Models & Mechanisms. 15 (2). doi:10.1242/dmm.049344. PMC 8821523. PMID 35103797.
Bahar, Md Entaz; Kim, Hyun Joon; Kim, Deok Ryong (2023-12-18). "Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies". Signal Transduction and Targeted Therapy. 8 (1). doi:10.1038/s41392-023-01705-z. ISSN 2059-3635. PMC 10725898.
Tidyman WE, Rauen KA (2016). "Pathogenetics of the RASopathies". Human Molecular Genetics. 25 (R2): R123 – R132. doi:10.1093/hmg/ddw191. PMC 6283265. PMID 27412009.
Riller Q, Rieux-Laucat F (2021). "RASopathies: From germline mutations to somatic and multigenic diseases". Biomedical Journal. 44 (4): 422–432. doi:10.1016/j.bj.2021.06.004. PMC 8514848. PMID 34175492.
Dunnett-Kane V, Burkitt-Wright E, Blackhall FH, Malliri A, Evans DG, Lindsay CR (2020). "Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts". Annals of Oncology. 31 (7): 873–883. doi:10.1016/j.annonc.2020.03.291. PMC 7322396. PMID 32240795.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Rai B, Naylor PE, Siqueiros-Sanchez M, Wintermark M, Raman MM, Jo B; et al. (2023). "Novel effects of Ras-MAPK pathogenic variants on the developing human brain and their link to gene expression and inhibition abilities". Translational Psychiatry. 13 (1): 245. doi:10.1038/s41398-023-02504-4. PMC 10322993. PMID 37407569.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Zenker M (2022). "Clinical overview on RASopathies". American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 190 (4): 414–424. doi:10.1002/ajmg.c.32015. PMID 36428239.
Aoki Y, Niihori T, Inoue S, Matsubara Y (2016). "Recent advances in RASopathies". Journal of Human Genetics. 61 (1): 33–9. doi:10.1038/jhg.2015.114. PMID 26446362.{{cite journal}}: CS1 maint: multiple names: authors list (link)

nih.gov

pubmed.ncbi.nlm.nih.gov

Boxel-Woolf, Tom Van; McCarthy, Kathleen M. "Speech and language skills in a case of Watson syndrome". Clinical Linguistics & Phonetics. 0 (0): 1–24. doi:10.1080/02699206.2025.2472051. ISSN 0269-9206. PMID 40077991.
Rauen KA (2022). "Defining RASopathy". Disease Models & Mechanisms. 15 (2). doi:10.1242/dmm.049344. PMC 8821523. PMID 35103797.
Tidyman WE, Rauen KA (2016). "Pathogenetics of the RASopathies". Human Molecular Genetics. 25 (R2): R123 – R132. doi:10.1093/hmg/ddw191. PMC 6283265. PMID 27412009.
Riller Q, Rieux-Laucat F (2021). "RASopathies: From germline mutations to somatic and multigenic diseases". Biomedical Journal. 44 (4): 422–432. doi:10.1016/j.bj.2021.06.004. PMC 8514848. PMID 34175492.
Dunnett-Kane V, Burkitt-Wright E, Blackhall FH, Malliri A, Evans DG, Lindsay CR (2020). "Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts". Annals of Oncology. 31 (7): 873–883. doi:10.1016/j.annonc.2020.03.291. PMC 7322396. PMID 32240795.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Rai B, Naylor PE, Siqueiros-Sanchez M, Wintermark M, Raman MM, Jo B; et al. (2023). "Novel effects of Ras-MAPK pathogenic variants on the developing human brain and their link to gene expression and inhibition abilities". Translational Psychiatry. 13 (1): 245. doi:10.1038/s41398-023-02504-4. PMC 10322993. PMID 37407569.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Zenker M (2022). "Clinical overview on RASopathies". American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 190 (4): 414–424. doi:10.1002/ajmg.c.32015. PMID 36428239.
Aoki Y, Niihori T, Inoue S, Matsubara Y (2016). "Recent advances in RASopathies". Journal of Human Genetics. 61 (1): 33–9. doi:10.1038/jhg.2015.114. PMID 26446362.{{cite journal}}: CS1 maint: multiple names: authors list (link)

ncbi.nlm.nih.gov

Rauen KA (2022). "Defining RASopathy". Disease Models & Mechanisms. 15 (2). doi:10.1242/dmm.049344. PMC 8821523. PMID 35103797.
Bahar, Md Entaz; Kim, Hyun Joon; Kim, Deok Ryong (2023-12-18). "Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies". Signal Transduction and Targeted Therapy. 8 (1). doi:10.1038/s41392-023-01705-z. ISSN 2059-3635. PMC 10725898.
Tidyman WE, Rauen KA (2016). "Pathogenetics of the RASopathies". Human Molecular Genetics. 25 (R2): R123 – R132. doi:10.1093/hmg/ddw191. PMC 6283265. PMID 27412009.
Riller Q, Rieux-Laucat F (2021). "RASopathies: From germline mutations to somatic and multigenic diseases". Biomedical Journal. 44 (4): 422–432. doi:10.1016/j.bj.2021.06.004. PMC 8514848. PMID 34175492.
Dunnett-Kane V, Burkitt-Wright E, Blackhall FH, Malliri A, Evans DG, Lindsay CR (2020). "Germline and sporadic cancers driven by the RAS pathway: parallels and contrasts". Annals of Oncology. 31 (7): 873–883. doi:10.1016/j.annonc.2020.03.291. PMC 7322396. PMID 32240795.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Rai B, Naylor PE, Siqueiros-Sanchez M, Wintermark M, Raman MM, Jo B; et al. (2023). "Novel effects of Ras-MAPK pathogenic variants on the developing human brain and their link to gene expression and inhibition abilities". Translational Psychiatry. 13 (1): 245. doi:10.1038/s41398-023-02504-4. PMC 10322993. PMID 37407569.{{cite journal}}: CS1 maint: multiple names: authors list (link)

tandfonline.com

Boxel-Woolf, Tom Van; McCarthy, Kathleen M. "Speech and language skills in a case of Watson syndrome". Clinical Linguistics & Phonetics. 0 (0): 1–24. doi:10.1080/02699206.2025.2472051. ISSN 0269-9206. PMID 40077991.

worldcat.org

search.worldcat.org

Boxel-Woolf, Tom Van; McCarthy, Kathleen M. "Speech and language skills in a case of Watson syndrome". Clinical Linguistics & Phonetics. 0 (0): 1–24. doi:10.1080/02699206.2025.2472051. ISSN 0269-9206. PMID 40077991.
Bahar, Md Entaz; Kim, Hyun Joon; Kim, Deok Ryong (2023-12-18). "Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies". Signal Transduction and Targeted Therapy. 8 (1). doi:10.1038/s41392-023-01705-z. ISSN 2059-3635. PMC 10725898.